loader2
Partner With Us NRI

Zydus Lifesciences Ltd share Price Today

Company details

985.00
1,021.00
478.20
1,027.80
6M Return 66.46%
1Y Return 109.04%
Mkt Cap.(Cr) 101,964.37
Volume 1,873,843
Div Yield 0.60%
OI
-
OI Chg %
-
Volume 1,873,843

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Decent performance; US pipeline, India traction key…
About The Stock

    Zydus is a leading pharma company with family pedigree having a presence in domestic branded formulations, US generics and is in the process of repurposing itself into niche areas of specialty pharmaceuticals, biosimilars and vaccines.
    • FY22 revenue break-up – US: 39%, India: 32%, Wellness: 13%, Europe & emerging markets including countries in LatAm, Asia Pacific & Africa: 10%
    • Zydus is the fourth largest pharma company in India with 14 brands among Top 300 pharma brands in India and nine with ₹ 100 crore+ sales

Q1FY23

    India growth impacted by higher Covid base (9% YoY growth ex-Covid, generics portfolio and divested products) while US price erosion eased.
    • Sales were up 2% YoY to ₹ 4073 crore (ex-Covid: up 11% YoY)
    • EBITDA was at ₹ 833 crore, down 14% YoY with margins at 20.5%
    • Adjusted PAT was at ₹ 529 crore (down 11% YoY)

Click here for full recommendation

Research view on more stocks

Zydus Lifesciences Ltd shares SWOT Analysis

Strengths (7)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with high TTM EPS Growth
  • Company with Low Debt

Weakness (2)

  • Declining profits every quarter for the past 2 quarters
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (2)

  • Highest Recovery from 52 Week Low
  • RSI indicating price strength

Threats (1)

  • Companies with growing costs YoY for long term projects

Resistance and support

R1 1,023.9
R2 1,040.5
R3 1,059.9
Pivot

1,004.45

S1 987.9
S2 968.5
S3 951.9
EMA SMA
970.6
894.7
808.6
713.4
975.4
880.1
769.4
687.5
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
INTEGRATED CORE STRATEGIES (ASIA) PTE.LTD. Bulk Purchase 2019-05-28 258.21 5460159 NSE
BLACKROCK FUNDS INTERNATIONAL OPPORTUNITIES PORTF Bulk Purchase 2015-11-30 403 7102797 NSE
BLACKROCK FUNDS INTERNATIONAL OPPORTUNITIES PORTF Bulk Sell 2015-11-30 402.79 555000 NSE
Name Category Shares
Zydus Family Trust (Pankaj R. Patel, Pritiben P. Patel and Sharvil P. Patel-Trustees) PROMOTER 74.96%

OUR RESEARCH VIEW

Investment recommendation
Decent performance; US pipeline, India traction key…
Call Date
04 Feb 2023
Entry Price 430.00
Target Price 500.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Zydus Lifesciences Ltd Stocks COMPARISON

Financials( in Cr) Zydus Lifesciences Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Mankind Pharma Ltd
Price 1,007.35 1,620.55 1,496.95 6,157.90 2,300.75
% Change 0.77 1.02 2.30 1.88 -1.52
Mcap Cr 101,964.37 388,824.23 120,856.26 102,719.31 92,165.28
Revenue TTM Cr 17,237.40 43,885.68 15,790.60 24,669.70 8,749.43
Net Profit TTM Cr 1,997.30 8,560.84 2,513.47 4,507.30 1,309.68
PE TTM 30.34 41.13 29.93 19.30 54.12
1 Year Return 109.04 64.78 68.33 37.28 61.76
ROCE 16.25 16.79 14.76 25.99 23.11
ROE 14.05 16.46 10.66 21.21 19.27
INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 17,515.80 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 30,755.54 31,723.05
LAST 3M 69,913.40 26,515.65
LAST 6M 130,081.93 60,306.69
LAST 12M 189,259.39 205,003.99
Zydus Lifesciences Limited - Updates

Mar 26, 2024 l NSE Announcement

Zydus receives USFDA tentative approval for Letermovir tablets

Mar 23, 2024 l BSE Announcement

Zydus Lifesciences Limited - Updates

Mar 22, 2024 l NSE Announcement

Date Action Type Ratio
Jul 28, 2023 Dividend 600
Jul 28, 2022 Dividend 250

Zydus Lifesciences Ltd Information

Stock PE (TTM)
30.34
Promoter Holding
74.98%
Book Value
185.0696
ROCE
16.25%
ROE
14.05%
Registered Address

Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W, Ahmedabad, Gujarat, 382481

Tel : 91-079-26868100
Email : dhavalsoni:zyduscadila.com; upen.shah:zyduscadila.
Website : http://www.zyduscadila.com
Registrar

Sharepro Services India P Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 532321
NSE Code : ZYDUSLIFE
Book Closure Date (Month) :
BSE Group : A
ISIN : INE010B01027

FAQ’s on Zydus Lifesciences Ltd Shares

You can buy Zydus Lifesciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Zydus Lifesciences Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Mar 28, 2024 04:09 PM the closing price of Zydus Lifesciences Ltd was ₹ 1,007.35.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 28, 2024 04:09 PM, the market cap of Zydus Lifesciences Ltd stood at ₹ 101,964.37.

The latest PE ratio of Zydus Lifesciences Ltd as of Mar 28, 2024 04:09 PM is 30.34

The latest PB ratio of Zydus Lifesciences Ltd as of Mar 28, 2024 04:09 PM is 0.19

The 52-week high of Zydus Lifesciences Ltd share price is ₹ 1,027.80 while the 52-week low is ₹ 478.20

According to analyst recommendations, Zydus Lifesciences Ltd Share has a “Buy” rating for the long term.

Download Our

Download App
market app